📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Checkmate Pharmaceuticals

1.1 - Company Overview

Checkmate Pharmaceuticals Logo

Checkmate Pharmaceuticals

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of clinical-stage biopharmaceutical research and development focused on cancer immunotherapy, leveraging expertise in CpG oligonucleotides to discover and develop novel immunotherapies aimed at enabling more people with cancer to benefit from these treatments.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Checkmate Pharmaceuticals

Genmab Logo

Genmab

HQ: Denmark Website
  • Description: Provider of fully human antibody therapeutics for potential cancer treatment, including investigational Rinatabart Sesutecan with promising anti-tumor activity in heavily pretreated ovarian and endometrial cancer patients; offers AI-powered target identification and candidate design, AI-enhanced clinical trial optimization, and collaboration with technology and academic organizations.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Genmab company profile →
Grid Therapeutics Logo

Grid Therapeutics

HQ: United States Website
  • Description: Provider of AI-driven platforms and therapeutics for cancer, including GT103, a human-derived antibody targeting a tumor-specific epitope for lung and other cancers. Offerings include high-throughput antibody discovery without prior protein knowledge, an AI-driven data warehouse, computational biology tools, a tumor vaccine design program, and a Phase 1b NSCLC study of GT103.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Grid Therapeutics company profile →
xCella Biosciences Logo

xCella Biosciences

HQ: United States Website
  • Description: Provider of antibody discovery technologies, offering a platform to screen single B cells and develop therapeutics via protein engineering. Products include the OmniAb Discovery Platform and transgenic animal systems: OmniRat, OmniMouse, OmniChicken for generating fully human antibodies; OmniFlic and OmniClic for bispecific discovery; and xPloration integrated hardware/software for high-dimensional measurement and analysis.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full xCella Biosciences company profile →
Affinivax Logo

Affinivax

HQ: United States Website
  • Description: Provider of vaccine R&D targeting infectious diseases, using its MAPS (Multiple Antigen Presenting System) platform to enable broader coverage by combining polysaccharides and proteins. Offerings include AFX3772, a 24-valent pneumococcal vaccine candidate in phase II for S. pneumoniae prevention in adults and children, and a 30-plus valent pneumococcal candidate in pre-clinical development.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Affinivax company profile →
Faron Pharmaceuticals Logo

Faron Pharmaceuticals

HQ: Finland Website
  • Description: Provider of clinical-stage biopharmaceutical therapies targeting acute organ trauma, vascular damage, and cancer immunotherapy, including bexmarilimab, a humanized monoclonal antibody against Clever-1 on macrophages to modify the tumor microenvironment and boost anti-tumor immune response, and Traumakine, an intravenous interferon beta-1a to prevent multiorgan dysfunction and mitigate CAR-T side effects (cytokine release syndrome, neurotoxicity).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Faron Pharmaceuticals company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Checkmate Pharmaceuticals

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Checkmate Pharmaceuticals

2.2 - Growth funds investing in similar companies to Checkmate Pharmaceuticals

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Checkmate Pharmaceuticals

4.2 - Public trading comparable groups for Checkmate Pharmaceuticals

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Checkmate Pharmaceuticals

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Checkmate Pharmaceuticals

What does Checkmate Pharmaceuticals do?

Checkmate Pharmaceuticals is a provider of clinical-stage biopharmaceutical research and development focused on cancer immunotherapy, leveraging expertise in CpG oligonucleotides to discover and develop novel immunotherapies aimed at enabling more people with cancer to benefit from these treatments.

Who are Checkmate Pharmaceuticals's competitors?

Checkmate Pharmaceuticals's competitors and similar companies include Genmab, Grid Therapeutics, xCella Biosciences, Affinivax, and Faron Pharmaceuticals.

Where is Checkmate Pharmaceuticals headquartered?

Checkmate Pharmaceuticals is headquartered in United States.

How many employees does Checkmate Pharmaceuticals have?

Checkmate Pharmaceuticals has 1,000 employees 🔒.

When was Checkmate Pharmaceuticals founded?

Checkmate Pharmaceuticals was founded in 2010 🔒.

What sector and industry vertical is Checkmate Pharmaceuticals in?

Checkmate Pharmaceuticals is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Checkmate Pharmaceuticals

Who are the top strategic acquirers in Checkmate Pharmaceuticals's sector and industry

Top strategic M&A buyers and acquirers in Checkmate Pharmaceuticals's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Checkmate Pharmaceuticals?

Top strategic M&A buyers groups and sectors for Checkmate Pharmaceuticals include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Checkmate Pharmaceuticals's sector and industry vertical

Which are the top PE firms investing in Checkmate Pharmaceuticals's sector and industry vertical?

Top PE firms investing in Checkmate Pharmaceuticals's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Checkmate Pharmaceuticals's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Checkmate Pharmaceuticals's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Checkmate Pharmaceuticals's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Checkmate Pharmaceuticals include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Checkmate Pharmaceuticals's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Checkmate Pharmaceuticals?

The key public trading comparables and valuation benchmarks for Checkmate Pharmaceuticals include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Checkmate Pharmaceuticals for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Checkmate Pharmaceuticals with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Checkmate Pharmaceuticals's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Checkmate Pharmaceuticals with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Checkmate Pharmaceuticals's' sector and industry vertical?

Access recent funding rounds and capital raises in Checkmate Pharmaceuticals's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Checkmate Pharmaceuticals